Grünenthal GmbH Company Profile

04:02 EDT 18th March 2018 | BioPortfolio





Phone: 49 241 569 - 1522

News Articles [126 Associated News Articles listed on BioPortfolio]

Grünenthal changes partner for US opioid drug marketing

German family-owned drugmaker Grünenthal has decided to end its partnership with US firm Depomed for…

Grünenthal and Mundipharma Enter Commercial Partnership in China

Developed by Grünenthal, Tramal ®is a well-established analgesic for the treatment of moderate to severe pain. It is the only international brand of tramadol Read more...

BRIEF—Mundipharma to distribute Grünenthal's analgesic Tramal in China

Privately-held firms Grünenthal and Mundipharma have agreed a licensing and distribution deal for the…

Mundipharma to distribute Grünenthal’s pain-relief drug in China

German firm GrÃnenthal has signed a license and distribution deal with Mundipharma for the formerâs analgesic Tramal (tramadol).

Grünenthal deal makes it 2nd largest women’s health company in Latin America

Family-owned German pharma Grünenthal is to distribute, promote and sell Merck & Co’s women health…

Mundipharma agrees to distribute Grünenthal's pain-relief drug in China

Mundipharma has agreed to market and distribute Grünenthal’s Tramal (tramadol) in China from 1 May 2018.

Mundipharma signs Chinese licensing and distribution agreement with Grünenthal

US-based firm Mundipharma is set to take over commercialisation and distribution duties for the analgesic Tramal (tramadol) in China on behalf of Grünenthal, it has emerged. Mundipharma has signed a ...

Grünenthal in US$300m deal with AstraZeneca

PubMed Articles [13 Associated PubMed Articles listed on BioPortfolio]

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Postoperative Corneal Asphericity in Low, Moderate, and High Myopic Eyes After Transepithelial PRK Using a New Pulse Allocation.

To evaluate the postoperative asphericity in low, moderate, and high myopic eyes after combined transepithelial photorefractive keratectomy and SmartSurfACE treatment (SCHWIND eye-tech-solutions GmbH,...

Reliability of a Skin Diagnostic Device in Assessing Hydration and Erythema.

To examine the reliability of a skin diagnostic device, the SD202 (Courage+Khazaka GmBH, Cologne, Germany), in assessing hydration and erythema of periwound skin and pressure injury-prone areas.

Clinical Trials [42 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Companies [530 Associated Companies listed on BioPortfolio]

Grünenthal Group

The Grünenthal Group is an independent, family-owned company, headquartered in Aachen, Germany. It is present in 32 countries with affiliates in Europe, Latin America and the U...


Grünenthal è una società farmaceutica indipendente, basata sulla ricerca con operazioni internazionali. E' sempre stata una società a capitale privato fin dalla sua fondazione nel 1946. I prodotti...

Grünenthal GmbH



Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

More Information about "Grünenthal GmbH" on BioPortfolio

We have published hundreds of Grünenthal GmbH news stories on BioPortfolio along with dozens of Grünenthal GmbH Clinical Trials and PubMed Articles about Grünenthal GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Grünenthal GmbH Companies in our database. You can also find out about relevant Grünenthal GmbH Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record